{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:06:08Z","timestamp":1794344768855,"version":"4.9.0"},"publisher-location":"Chichester, UK","reference-count":52,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd005198.pub2","type":"reference-entry","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T14:25:39Z","timestamp":1170771939000},"source":"Crossref","is-referenced-by-count":4,"title":["Therapeutic interventions for Burkitt's lymphoma in children"],"prefix":"10.1002","author":[{"given":"Joseph U","family":"Okebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby J","family":"Lasserson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin M","family":"Meremikwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,10,18]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD005198.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198303103081003","article-title":"Childhood non-Hodgkin's lymphoma. The results of a randomised therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)","volume":"308","author":"Anderson","year":"1983","journal-title":"The New England journal of medicine"},{"issue":"6","key":"10.1002\/14651858.CD005198.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/(SICI)1096-911X(199712)29:6<526::AID-MPO2>3.0.CO;2-M","article-title":"Fractionated cyclophosphamide and back to back high dose methrotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (snccl): a randomised trial of the pediatric oncology group","volume":"29","author":"Brecher","year":"1997","journal-title":"Medical and Pediatric oncology"},{"key":"10.1002\/14651858.CD005198.pub2-BIB3|cit3","series-title":"Procdeedings of the American society of Clinical Oncology","first-page":"796","article-title":"Results of a randomised FAB LMB89 international study in children and adolescents (C+A) with advanced (bone marrow [BM] [B-ALL] and\/or CNS) B-NHL (large cell [LCL], Burkitt's [BM] and Burkitt-like [BLL]): Pts with L3 leukemia\/ CNS- have an excellent prognosis.","author":"Cairo","year":"2003"},{"key":"10.1002\/14651858.CD005198.pub2-BIB4|cit4","first-page":"67","article-title":"Prophylaxis of meningeal Burkitt's lymphoma with CCNU","volume":"14","author":"Magrath","year":"1973","journal-title":"American association for cancer research"},{"key":"10.1002\/14651858.CD005198.pub2-BIB6|cit5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/bmj.1.6010.615","article-title":"Failure of BCG immunostimulation to affect the clinical course of Burkitt's Lymphoma","volume":"1","author":"Magrath","year":"1976","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD005198.pub2-BIB5|cit6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/978-3-642-49284-6_67","article-title":"Preliminary results of a randomized trial of BCG immunotherapy in Burkitt's lymphoma","volume":"47","author":"Magrath","year":"1974","journal-title":"Recent results in cancer research"},{"key":"10.1002\/14651858.CD005198.pub2-BIB8|cit7","first-page":"199","article-title":"BCG immunotherapy in Burkitt's lymphoma: preliminary results of a randomized clinical trial","volume":"39","author":"Ziegler","year":"1973","journal-title":"National cancer institute monograph"},{"key":"10.1002\/14651858.CD005198.pub2-BIB7|cit8","series-title":"Proceedings of the American association for cancer research","first-page":"38","article-title":"BCG immunotherapy of Burkitt's lymphoma.","author":"Ziegler","year":"1972"},{"issue":"5A","key":"10.1002\/14651858.CD005198.pub2-BIB9|cit9","first-page":"1183","article-title":"Specific transfer factor with activity against Ebstein-Barr virus reduces late relapse in endemic Burkitt's lymphoma","volume":"10","author":"Neequaye","year":"1990","journal-title":"Anticancer research"},{"issue":"4","key":"10.1002\/14651858.CD005198.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ijc.2910170404","article-title":"Treatment of Burkitt's lymphoma: randomized clinical trial of single-agent versus combination chemotherapy","volume":"17","author":"Olweny","year":"1976","journal-title":"Journal International du cancer"},{"issue":"3","key":"10.1002\/14651858.CD005198.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/02841867709133941","article-title":"Cerebrospinal irradiation of Burkitt's lymphoma","volume":"16","author":"Olweny","year":"1977","journal-title":"Acta radiologica: therapy, physics, biology"},{"issue":"1","key":"10.1002\/14651858.CD005198.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JCO.1991.9.1.123","article-title":"High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French pediatric oncology society of a randomized trial of 216 children","volume":"9","author":"Patte","year":"1991","journal-title":"Journal of clinical oncology"},{"issue":"3","key":"10.1002\/14651858.CD005198.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00043426-199123000-00007","article-title":"High-dose Cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a pediatric oncology group study","volume":"13","author":"Sullivan","year":"1991","journal-title":"The American journal of pediatric hematology \/oncology"},{"issue":"773","key":"10.1002\/14651858.CD005198.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/bmj.3.5773.508","article-title":"Intrathecal chemotherapy in Burkitt's lymphoma","volume":"3","author":"Ziegler","year":"1971","journal-title":"British medical journal"},{"issue":"2","key":"10.1002\/14651858.CD005198.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ijc.2910100205","article-title":"Intensive chemotherapy in patients with generalized Burkitt's lymphoma","volume":"10","author":"Ziegler","year":"1972","journal-title":"International journal of cancer"},{"issue":"2 suppl 4","key":"10.1002\/14651858.CD005198.pub2-BIB16|cit16","first-page":"33","article-title":"Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas","volume":"25","author":"Adde","year":"1998","journal-title":"Seminars in oncology"},{"issue":"6","key":"10.1002\/14651858.CD005198.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0964-1955(96)00031-0","article-title":"Marginal zone B cell lymphoma of the parotid glands","volume":"32B","author":"Aviles","year":"1996","journal-title":"European journal of cancer part B, oral oncology"},{"issue":"1","key":"10.1002\/14651858.CD005198.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a057673","article-title":"Peripheral T-cell lymphocytes have a poorer prgnosis thab B-cell lympomas: A prospective study of 361 immunotyped patients treated with LNH-84 regimen","volume":"1","author":"Coiffier","year":"1990","journal-title":"Journal of the European society for medical oncology\/ESMO"},{"issue":"10","key":"10.1002\/14651858.CD005198.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2000.18.10.2017","article-title":"Outcome of CNS disease at diagnosis in disseminated small non-cleaved cell lymphoma and B-cell leukaemia: a children's cancer group study","volume":"18","author":"Gururagan","year":"2000","journal-title":"Journal of clinical oncology"},{"issue":"6","key":"10.1002\/14651858.CD005198.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1200\/JCO.2005.12.191","article-title":"Maximising therapeutic effect of rituximab: maintenance treatment vs. re-treatment at progression in patients with indolent non-Hodgkin's lymphoma- a randomized phase two trial of the Minie Pearl research network","volume":"23","author":"Hainsworth","year":"2005","journal-title":"Journal of clinical oncology"},{"key":"10.1002\/14651858.CD005198.pub2-BIB21|cit21","series-title":"5th international conference on malignant lymphoma","first-page":"85a","article-title":"Comparison of autologous bone marrow transplantation (BMT) with sequential chemotherapy for aggressive non-Hodgkin's lymphoma in first remission: a study on 464 patients (LNH 87 protocol)","author":"Haioun","year":"1993"},{"issue":"9","key":"10.1002\/14651858.CD005198.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V89.9.3129","article-title":"Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma- long term results of a clinical trial","volume":"89","author":"Hsu","year":"1997","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD005198.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1200\/JCO.1991.9.6.929","article-title":"Clinical and virologic effects of recombinant human-granulocyte colony stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial","volume":"9","author":"Kaplan","year":"1991","journal-title":"Journal of clinical oncology"},{"key":"10.1002\/14651858.CD005198.pub2-BIB24|cit24","series-title":"5th international conference on malignant lymphoma","article-title":"Chlorambucil\/prednisolone (CHP) versus CHOP in symptomatic low grade lymphomas","author":"Kimby","year":"1993"},{"issue":"1","key":"10.1002\/14651858.CD005198.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jama.266.1.84","article-title":"Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS- related lymphoma","volume":"266","author":"Levine","year":"1991","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/14651858.CD005198.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1182\/blood.V84.8.2457.2457","article-title":"Phase I clinical trial using escalating single-dose infusion of chimeric Anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma","volume":"84","author":"Maloney","year":"1994","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD005198.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1200\/JCO.1997.15.10.3266","article-title":"IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma","volume":"15","author":"Maloney","year":"1997","journal-title":"Journal of clinical oncology"},{"issue":"10","key":"10.1002\/14651858.CD005198.pub2-BIB28|cit28","first-page":"585","article-title":"Treatment of histiocytic lymphoma in Ugandan adults","volume":"48","author":"Olweny","year":"1971","journal-title":"East African medical journal"},{"issue":"3","key":"10.1002\/14651858.CD005198.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/blood-2003-06-2094","article-title":"Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSNHL.","volume":"104","author":"Pfreundschuh","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD005198.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-2008-1046608","article-title":"NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 1: classification and allocation to strategic therapy groups. BIF study group","volume":"206","author":"Reiter","year":"1994","journal-title":"Klinische padiatrie"},{"issue":"4","key":"10.1002\/14651858.CD005198.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-2008-1046610","article-title":"NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: an intermediate term analysis of the B-NHL\/B-ALL.","volume":"204","author":"Reiter","year":"1994","journal-title":"Klinische padiatrie"},{"issue":"6","key":"10.1002\/14651858.CD005198.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1200\/JCO.2000.18.6.1309","article-title":"Randomized comparison of ACVBP and m-BACOD in the treatment o patients with low-risk aggressive lymphoma: the LNH87-1 study","volume":"18","author":"Tilly","year":"2000","journal-title":"Journal of clinical oncology"},{"issue":"(suppl 1)","key":"10.1002\/14651858.CD005198.pub2-BIB33|cit33","first-page":"74","article-title":"MACOP-B vs. MACHOP in the treatment of high-grade non-Hodgkin's lymphoma","volume":"5","author":"Tura","year":"1991","journal-title":"Leukemia"},{"issue":"(suppl 12)","key":"10.1002\/14651858.CD005198.pub2-BIB34|cit34","first-page":"74","article-title":"The use of Ibritumomab tiuxetan radioimmunology for patients with relapsed B-cell non-Hodgkin's lymphoma","volume":"27","author":"Witzig","year":"2000","journal-title":"Seminars in oncology"},{"issue":"10","key":"10.1002\/14651858.CD005198.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1200\/JCO.2002.11.076","article-title":"Randomized controlled trial of Yttrium-90-labeled Ibritumomab Tiuxetan radioimmunotherapy versus Rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma","volume":"20","author":"Witzig","year":"2002","journal-title":"Journal of clinicaloncology"},{"key":"10.1002\/14651858.CD005198.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0165-4608(81)90039-X","article-title":"Cytogenic studies on African Burkitt's lymphoma cell lines; t(8;14),t(2;8), and t(8;22) translocations","volume":"3","author":"Bernheim","year":"1981","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1002\/14651858.CD005198.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bjs.18004619704","article-title":"Sarcoma involving jaws in African children","volume":"46","author":"Burkitt","year":"1958","journal-title":"British journal of surgery"},{"key":"10.1002\/14651858.CD005198.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1365-2141.2003.04134.x","article-title":"Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience.","volume":"4","author":"Cairo","year":"2003","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD005198.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/tropej\/36.3.114","article-title":"Burkitt's lymphoma and the role of Ebstein- Barr virus","volume":"30","author":"Goldstein","year":"1990","journal-title":"Journal of tropical paediatrics"},{"key":"10.1002\/14651858.CD005198.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/978-3-642-49284-6_67","article-title":"Preliminary results of a randomized trial of BCG immunotherapy in Burkitt's lymphoma.","volume":"47","author":"Magrath","year":"1974","journal-title":"Recent results in cancer research"},{"key":"10.1002\/14651858.CD005198.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/bmj.2.5914.308","article-title":"Surgical reduction of tumor bulk in management of abdominal Burkitt's Lymphoma","volume":"2","author":"Magrath","year":"1974","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD005198.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0889-8588(18)30642-7","article-title":"Malignant non-Hodgkin's lymphomas in children","volume":"1(4)","author":"Magrath","year":"1987","journal-title":"Hematology and oncology Clinics of North America"},{"issue":"11","key":"10.1002\/14651858.CD005198.pub2-BIB43|cit43","first-page":"41","article-title":"Biology and treatment of small non-cleaved cell lymphoma. Biology and treatment of small non-cleaved cell lymphoma. Biology and treatment of small non-cleaved cell lymphoma","volume":"3","author":"Magrath","year":"1989","journal-title":"Oncology"},{"key":"10.1002\/14651858.CD005198.pub2-BIB44|cit44","unstructured":"Meremikwu MM Ehiri JE Nkanga DG Udoh EE Ikpatt OF Alaje EO Socio-economic constraints to effective management of Burkitt's lymphoma in south-east Nigeria Tropical medicine and international health"},{"key":"10.1002\/14651858.CD005198.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/02841867109129766","article-title":"Conventional and superfractionated radiation therapy in Burkit's lymphoma","volume":"10","author":"Norlin","year":"1971","journal-title":"Acta Radiologica"},{"issue":"4","key":"10.1002\/14651858.CD005198.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1179\/027249302125002038","article-title":"Epidemiology of Burkitt's lymphoma in Enugu, Nigeria","volume":"22","author":"Oguonu","year":"2002","journal-title":"Annals of tropical paediatrics"},{"issue":"3","key":"10.1002\/14651858.CD005198.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ijc.2910260302","article-title":"Long-term experience with Burkitt's lymphoma in Uganda","volume":"26","author":"Olweny","year":"1980","journal-title":"International journal of cancer"},{"issue":"7","key":"10.1002\/14651858.CD005198.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/annonc\/mdh262","article-title":"Treatment of Burkitt's\/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens.","volume":"15","author":"Smeland","year":"2004","journal-title":"Annals of Oncology"},{"issue":"10","key":"10.1002\/14651858.CD005198.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1158\/0008-5472.CAN-04-0079","article-title":"Steps involed in immortalization and tumorigenesis of human b-lymphoblastoid cell lines transformed by Epstein-Barr virus","volume":"64","author":"Sugimoto","year":"2004","journal-title":"Cancer research"},{"key":"10.1002\/14651858.CD005198.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/1097-0142(197212)30:6<1534::AID-CNCR2820300619>3.0.CO;2-6","article-title":"Chemotherapy of Burkitt's lymphoma","volume":"30","author":"Ziegler","year":"1972","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD005198.pub2-BIB51|cit51","volume-title":"Pathology annual","author":"Ziegler","year":"1974"},{"key":"10.1002\/14651858.CD005198.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM198109243051305","article-title":"Burkitt's Lymphoma","volume":"305","author":"Ziegler","year":"1981","journal-title":"New England Journal of Medicine"}],"updated-by":[{"DOI":"10.1002\/14651858.cd005198.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T00:00:00Z","timestamp":1309910400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005198.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:46:19Z","timestamp":1628531179000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005198.pub2"}},"subtitle":[],"editor":[{"given":"Joseph U","family":"Okebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2006,10,18]]},"references-count":52,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005198.pub2","relation":{},"subject":[],"published":{"date-parts":[[2006,10,18]]}}}